In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Ingrid Fricke-GalindoHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0003-2132-1076 Salvador García-CarmonaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-5195-7385 Brandon Bautista-BecerrilHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0001-5975-6724 Gloria Pérez-RubioHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-6876-1012 Ivette Buendia-RoldanTranslational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-2825-506X Leslie Chávez-GalánLaboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0002-2334-0361 Karol J Nava-QuirozHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0003-4418-2646 Jesús Alanis-PonceHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0001-9902-7470 Juan M Reséndiz-HernándezLaboratorio Clínico, Centro Especializado de Atención a Personas con Discapacidad Visual, Instituto de Salud del Estado de México, Naucalpan 53000, Mexico State, Mexico.
Esther Blanco-AguilarFacultad de Medicina Benemérita, Universidad Autónoma de Puebla, Puebla de Zaragoza 72420, Puebla, Mexico.
Jessica I Erives-SedanoInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez 32310, Chihuahua, Mexico.ORCID 0009-0003-5371-3522 Yashohara Méndez-VelascoUnidad Académica Profesional Chimalhuacán, Universidad Autónoma del Estado de México, Nezahualcóyotl 56353, Mexico State, Mexico.ORCID 0009-0009-0330-947X Grecia E Osuna-EspinozaFacultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán Rosales 80030, Sinaloa, Mexico.ORCID 0009-0007-1399-1543 Fidel Salvador-HernándezEscuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico City 07320, Mexico.
Rubén Segura-CastañedaFacultad Interdisciplinaria de Ciencias Biológicas y de Salud, Universidad de Sonora, Hermosillo Sonora 83000, Sonora, Mexico.ORCID 0009-0002-9788-0069 Uriel N Solano-CandiaFacultad de Biología, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58000, Michoacán, Mexico.ORCID 0009-0006-2774-1492 Ramcés Falfán-ValenciaHLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.ORCID 0000-0001-6877-8124 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Genetic variants related to susceptibility to chronic respiratory conditions such as interstitial lung disease (ILD) could share critical pathways in the pathogenesis of COVID-19 and be implicated in COVID-19 outcomes and post-COVID-19. We aimed to identify the participation of genetic variants in lung function and ILD genes in severe COVID-19 outcomes and post-COVID-19 condition. We studied 936 hospitalized patients with COVID-19. The requirement of invasive mechanical ventilation (IMV) and the acute respiratory distress syndrome (ARDS) classification were considered. The mortality was assessed as the in-hospital death. The post-COVID-19 group included 102 patients evaluated for pulmonary function tests four times during the year after discharge. Five variants (
Indexed as
COVID-19LungLung Diseases, InterstitialAgedFemaleGenetic Predisposition to DiseaseGTPase-Activating ProteinsHumansIntracellular Signaling Peptides and ProteinsMaleMiddle AgedPolymorphism, Single NucleotideRespiratory Distress SyndromeRespiratory Function TestsSARS-CoV-2Severity of Illness IndexFAM13A protein, humanGTPase-Activating ProteinsIntracellular Signaling Peptides and ProteinsTOLLIP protein, humanCOVID-19DSPFAM13Ainterstitial lung diseasesinvasive mechanical ventilationpost-COVID-19pulmonary functionTERTTHSD4
Identifiers
PMID40076669
PMCPMC11900979
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390